Catalyst Wire Dossier Catalyst Wire Dossier

Ponesimod

ponesimod · Actelion
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Ponesimod, covering 2014-05-13 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]

See pricing